P526: REAL-WORLD COMPARISON OF DIFFERENT TREATMENT MODALITIES FOR FAVORABLE RISK ACUTE MYELOID LEUKEMIA: STANDARD DOSE ANTHRACYCLINE VS HIGH DOSE ANTHRACYCLINE VS ADDITION OF GEMTU... by J. Mort, B. Brewer, B. Mautner, S. Dibenedetto, E. Pierce, E. Morse, L. Wells, F. Ghamsari, A. Morris, S. Clark, J. Reid, I. Patel, C. Jackson, M. Perciavalle, B. Yelvington, R. Miller, K. Abernathy, H. Wolfe, S. Locke, J. Zeidner, D. Reed, V. Duong, B. Dholaria, T. LeBlanc, M. Keng, B. Horton, F. El Chaer

Get full text

P354: REAL-WORLD ANALYSIS OF THE RISKS OF THROMBOTIC AND BLEEDING EVENTS IN PATIENTS RECEIVING PEGYLATED ASPARAGINASE FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA by B. Mautner, B. Brewer, J. Mort, E. Pierce, F. Ghamsari, S. Dibenedetto, E. Morse, L. Wells, A. Morris, C. Allen, I. Patel, D. D’Souza, C. Jackson, M. Perciavalle, B. Yelvington, R. Miller, K. Abernathy, K. Walsh, H. Wolfe, S. Locke, D. Reed, V. Duong, B. Dholaria, T. LeBlanc, R. Shallis, M. Keng, B. Horton, F. El Chaer

Get full text